EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Bazi Bushen Attenuates Skeletal Muscle Decline Associated With Oestrogen Deficiency and Modulates FGFR1 / ERK Signalling

Dezhi Huang iD, Na Xu, Qi Chu, Zhenhua Jia iD, Yan Wang iD, Jin Xu iD

Journal of Cellular and Molecular Medicine · 2026-11 · 30 (21)

DOI: 10.1111/jcmm.71407 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 30.10.2026. Verfasst von Dezhi Huang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Endocrine Glucose & Lipids Metabolism and Brain Aging, Ministry of Education; Department of Endocrinology, Shandong Provincial Hosp…. Hauptthemen laut MEDLINE: Estrogens, Muscle, Skeletal, Receptor, Fibroblast Growth Factor, Type 1, MAP Kinase Signaling System. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, the Taishan Scholar Construction Project Special Funding, the Shandong Provincial Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Postmenopausal oestrogen deficiency is associated with skeletal muscle loss and functional decline, thereby increasing the risk of sarcopenia in women. Considering the safety risks linked to hormone replacement therapy (HRT), alternative strategies are needed to attenuate skeletal muscle decline after menopause. A total of 24 female C57BL/6J mice were randomly assigned to four groups ( n = 6 per group): Sham‐operated (SHAM), ovariectomized (OVX), OVX treated with estradiol valerate (OVX + E2) and OVX treated with Bazi Bushen (OVX + BZBS). Skeletal muscle mass and function were evaluated in four groups. RNA sequencing was applied to explore the molecular mechanisms and key signalling pathways underlying BZBS‐induced muscle protection. We further examined the role of the FGFR1/ERK signalling pathway in mediating the effects of BZBS on myogenic differentiation in C2C12 myoblasts. The results showed that OVX mice had reduced grip strength and skeletal muscle mass, increased fat accumulation, reduced lean mass and impaired metabolic activity. These phenotypic alterations were accompanied by myofiber atrophy, increased collagen staining, endocrine perturbations and elevated expression of p16, p21, Atrogin‐1 and MuRF1. BZBS ameliorated these abnormalities. RNA‐seq suggested that FGF/MAPK signalling may be involved. In D‐gal‐treated C2C12 myoblasts, BZBS reduced Atrogin‐1 and MuRF1 expression while restoring MYHC and MYOG expression. Mechanistically, BZBS suppressed FGFR1/ERK signalling activation and bFGF partially reversed the protective effects of BZBS. Taken together, these findings suggest that FGFR1/ERK signalling may contribute to the protective effects of BZBS. Our findings provide evidence for the beneficial effects of BZBS on skeletal muscle deterioration associated with oestrogen deficiency.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EstrogensMuscle, SkeletalReceptor, Fibroblast Growth Factor, Type 1MAP Kinase Signaling SystemPlant ExtractsAnimalsFemaleMiceOvariectomyMice, Inbred C57BLSignal TransductionMyoblastsEstradiolCell Line

Stichwörter der Autor:innen

Bazi BushenFGFR1/ERK signallingoestrogen deficiencyskeletal muscle deterioration

Substanzen

EstrogensReceptor, Fibroblast Growth Factor, Type 1Fgfr1 protein, mousePlant ExtractsEstradiol

Autor:innen und Institutionen

  • Key Laboratory of Endocrine Glucose & Lipids Metabolism and Brain Aging, Ministry of Education; Department of Endocrinology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong,…
  • Shandong Key Laboratory of Endocrine Metabolism and Aging, Jinan, Shandong, China.
  • Shandong Institute of Endocrine and Metabolic Diseases, Jinan, Shandong, China.
  • State Key Laboratory for Innovation and Transformation of Luobing Theory, Hebei Yiling Hospital, Shijiazhuang, Hebei, China.
  • Shandong Provincial Hospital Affiliated to Shandong First Medical University, "Chuangxin China" Innovation Base of Stem Cell and Gene Therapy for Endocrine Metabolic Diseases, Jinan, Shandong, China.
  • Shandong Provincial Hospital Affiliated to Shandong First Medical University, Shandong Engineering Laboratory of Prevention and Control for Endocrine and Metabolic Diseases, Jinan, Shandong, China.

ORCID-Profile: Dezhi Huang, Zhenhua Jia, Yan Wang, Jin Xu

Förderung

  • National Key Research and Development Program of China
  • the Taishan Scholar Construction Project Special Funding
  • the Shandong Provincial Natural Science Foundation

Zitieren

APA

Huang, D., Xu, N., Chu, Q., Jia, Z., Wang, Y., & Xu, J. (2026). Bazi Bushen Attenuates Skeletal Muscle Decline Associated With Oestrogen Deficiency and Modulates FGFR1 / ERK Signalling. Journal of Cellular and Molecular Medicine, 30(21). https://doi.org/10.1111/jcmm.71407

Vancouver

Huang D, Xu N, Chu Q, Jia Z, Wang Y, Xu J. Bazi Bushen Attenuates Skeletal Muscle Decline Associated With Oestrogen Deficiency and Modulates FGFR1 / ERK Signalling. Journal of Cellular and Molecular Medicine. 2026;30(21). doi:10.1111/jcmm.71407

BibTeX
@article{Huang2026,
  author = {Huang, Dezhi and Xu, Na and Chu, Qi and Jia, Zhenhua and Wang, Yan and Xu, Jin},
  title = {Bazi Bushen Attenuates Skeletal Muscle Decline Associated With Oestrogen Deficiency and Modulates FGFR1 / ERK Signalling},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2026},
  volume = {30},
  number = {21},
  doi = {10.1111/jcmm.71407}
}
Kostenlos starten →